¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼ººó¼¾Æ®º´¿ø 2019³â Á¦30ȸ ´ëÇÑ°£ÇÐȸ Ãá°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2019-03-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼ººó¼¾Æ®º´¿ø 2019³â Á¦30ȸ ´ëÇÑ°£ÇÐȸ Ãá°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2019-03-09
±³À°ÀÏÀÚ : 2019-03-09
±³À°Àå¼Ò : ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦, ÃÊÀ½ÆÄ Hands-on ÀÌ·Ð:¼ººó¼¾Æ®º´¿ø ¾Ïº´¿ø 4Ãþ ±³À°½Ç, ½Ç±â: 2Ãþ ¼ÒÈ­±â³»°ú ¿Ü·¡  
±³À°ÁÖÁ¦ : 2019³â Á¦30ȸ ´ëÇÑ°£ÇÐȸ Ãá°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °æ±â-ÀÎõÁöȸ  
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-703-0051  
À̸ÞÀÏ : kasl@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 11 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í *»çÀüµî·Ï STS-ȸ¿ø, ÀüÀÓÀÇ. Àü°øÀÇ 20000¿ø/ºñȸ¿ø 30000¿ø STS+ÃÊÀ½ÆÄ Hands-on-ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 40000¿ø/ºñȸ¿ø 50000¿ø *ÇöÀåµî·Ï STS-ȸ¿ø, ÀüÀÓÀÇ. Àü°øÀÇ 30000¿ø/ºñȸ¿ø 40000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø ¾Ïº´¿ø 4Ãþ ±³À°½Ç 09:00~09:30 º¹ºÎ ÃÊÀ½ÆÄ ±âº» ½ºÄµ¹ý  ±èÈñ¾ð(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø ¾Ïº´¿ø 2Ãþ ¼ÒÈ­±â³»°ú ¿Ü·¡ 09:45~12:15 ÃÊÀ½ÆÄ Hands-on 1Â÷  À¯Á¤È¯, ÀÌÇѾÆ, À¯Á¤ÁÖ, ±è¤¤Å¼®, ±èÈñ¾ð, Á¶È¿Á¤(ÀÎÇÏÀÇ´ë, °í·ÁÀÇ´ë, ¼øõÇâÀÇ´ë, °­¿øÀÇ´ë, °¡Å縯ÀÇ´ë, ¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 09:40~10:05 Cardiovascular risk in ALD and NAFLD: How to assess and manage?  À庴±¹(°è¸íÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 10:05~10:30 Optimal timing of liver transplantation for severe alcoholic hepatitis  ÁÖµ¿Áø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 10:30~10:55 HCC surveillance in non-cirrhotic patients with ALD and NAFLD  ±èº¸Çö(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 11:10~11:30 Immunopathogenesis of ALD  ¹Ú¼öÇü(Ä«À̽ºÆ®) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 11:30~11:50 Identification of novel therapeutic targets for NAFLD progression  ÇÑ⿱(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 11:50~12:10 Crosstalk among nutrient, microbiome, and metabolites in ALD and NAFLD  °í±¤Ç¥(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 12:10~12:30 Non-invasive assessment of hepatic steatosis and fibrosis in ALD and NAFLD  ÀÌ¿µ¼±(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø ¾Ïº´¿ø 4Ãþ ±³À°½Ç 13:15~13:45 º¹ºÎ ÃÊÀ½ÆÄ °Ë»ç ½ºÄµ½ÃÀÇ Trouble Shooting  ±è¼ø¼±(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø ¾Ïº´¿ø 2Ãþ ¼ÒÈ­±â³»°ú ¿Ü·¡ 14:00~16:30 ÃÊÀ½ÆÄ Hands-on 2Â÷  ±è¼ø¼±, ½Å½Â°¢, ÀÓ¼±¿µ, ¼ÛÁ¤Àº, ÀÌÀ¯¸², ¹ÚÁ¤±æ(¾ÆÁÖÀÇ´ë, °¡ÃµÀÇ´ë, °í·ÁÀÇ´ë, ´ë±¸°¡Å縯ÀÇ´ë, °æºÏÀÇ´ë, ¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 13:30~14:00 ALD : From basic to clinic  Kenichi Ikejima(Juntendo University, Japan) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 14:00~14:30 NAFLD in ASIA  Vincent Wong(The Chinese Univ. of Hong Kong) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 14:45~15:00 Effects of modest alcohol use and gender on NAFLD outcome  ½Åµ¿Çö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 15:00~15:15 Prognosis and management of acute on chronic liver failure according to etiology  ¼Ûµµ¼±(°¡Å縯ÀÇ´ë) 
Åä·Ð 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 15:15~15:45 Pannel discussion  ±è»ó±Õ, ±è¿ø(¼øõÇâÀÇ´ë, ¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 15:45~16:05 ALD cases  À±¾ÆÀϸ°(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 03-09 ¼ººó¼¾Æ®º´¿ø º°°ü6Ãþ ¼ººó¼¾Æ®È¦ 16:05~16:25 NAFLD cases  Á¤½Â¿ø(¼øõÇâÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼ººó¼¾Æ®º´¿ø 2019³â Á¦30ȸ ´ëÇÑ°£ÇÐȸ Ãá°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2019-03-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2019-03-09
´ÙÀ½±Û ¼­¿ï´ëÇб³º´¿ø Radiosurgery: How far will it go? Neurosurgery Update 2019 Combined with Commemorating Retirement of Professor Dong Gyu Kim : 2019-03-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 34 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 40 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 21 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 24 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 25 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷